DE CESARIS, FRANCESCO
DE CESARIS, FRANCESCO
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury
2017 Muzzi, Mirko; Buonvicino, Daniela; De Cesaris, Francesco; Chiarugi, Alberto
Chronic headaches and medication overuse
2010 Geppetti P.; De Cesaris F.; Nicoletti P.; Benemei S.
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report
2021 Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F.
Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research
2020 Cosci F.; Svicher A.; Romanazzo S.; Maggini L.; De Cesaris F.; Benemei S.; Geppetti P.
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
2022 Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto
Emerging Pharmacological Treatments for Migraine in the Pediatric Population
2022 Iannone L.F.; De Cesaris F.; Geppetti P.
Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy
2019 Marconi E.; Pecchioli S.; Nica M.; Colombo D.; Mazzoleni F.; De Cesaris F.; Geppetti P.; Cricelli C.; Lapi F.
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series
2022 Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F.
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
2020 Delussi M.; Gentile E.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Roca M.E.; Roveta F.; Lupi C.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M.
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
2022 Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F.
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study
2020 Benemei S.; Lupi C.; De Cesaris F.; Lombardi N.; Bettiol A.; Chiarugi A.; Geppetti P.; Galli V.; Pracucci C.; Occupati B.; Mannaioni G.
Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study
2021 Cosci F.; Svicher A.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Guidi J.; Zipfel S.
Mental pain as a global person-centred outcome measure
2021 Cosci F.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Sensky T.
Mental Pain Questionnaire: An item response theory analysis
2019 Svicher, A.; Romanazzo, S.; De Cesaris, F.; Benemei, S.; Geppetti, P.; Cosci, F.
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure
2024 Cosci Fiammetta; Carrozzino Danilo; Patierno Chiara; Romanazzo Sara; Berrocal Carmen; Chiarugi Alberto; De Cesaris Francesco; Guiducci Serena; Mansueto Giovanni; Christensen KajSparle; Sensky Tom
Migraine during covid-19: Data from second wave pandemic in an Italian cohort
2021 Gentile E.; Delussi M.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Candida G.; Roveta F.; Lupi C.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Roca M.E.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M.
Migraine Models
2009 S. Benemei; F. De Cesaris; P. Nicoletti; S. Materazzi; R. Nassini; P. Geppetti.
Migraine-provoking substances evoke periorbital allodynia in mice
2019 De Logu F.; Landini L.; Janal M.N.; Li Puma S.; De Cesaris F.; Geppetti P.; Nassini R.
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study
2024 Burgalassi, Andrea; Romozzi, Marina; Vigani, Giulia; De Icco, Roberto; Raffaelli, Bianca; Boccalini, Alberto; De Cesaris, Francesco; Calabresi, Paolo; Geppetti, Pierangelo; Chiarugi, Alberto; Iannone, Luigi Francesco
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses
2017 Felici, Roberta; Buonvicino, Daniela; Muzzi, Mirko; Cavone, Leonardo; Guasti, Daniele; Lapucci, Andrea; Pratesi, Sara; De Cesaris, Francesco; Luceri, Francesca; Chiarugi, Alberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury | 2017 | Muzzi, Mirko; Buonvicino, Daniela; De Cesaris, Francesco; Chiarugi, Alberto | |
| Chronic headaches and medication overuse | 2010 | Geppetti P.; De Cesaris F.; Nicoletti P.; Benemei S. | |
| COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report | 2021 | Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F. | |
| Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research | 2020 | Cosci F.; Svicher A.; Romanazzo S.; Maggini L.; De Cesaris F.; Benemei S.; Geppetti P. | |
| Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine | 2022 | Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto | |
| Emerging Pharmacological Treatments for Migraine in the Pediatric Population | 2022 | Iannone L.F.; De Cesaris F.; Geppetti P. | |
| Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy | 2019 | Marconi E.; Pecchioli S.; Nica M.; Colombo D.; Mazzoleni F.; De Cesaris F.; Geppetti P.; Cricelli C.; Lapi F. | |
| Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series | 2022 | Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F. | |
| Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) | 2020 | Delussi M.; Gentile E.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Roca M.E.; Roveta F.; Lupi C.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M. | |
| Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score | 2022 | Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F. | |
| Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study | 2020 | Benemei S.; Lupi C.; De Cesaris F.; Lombardi N.; Bettiol A.; Chiarugi A.; Geppetti P.; Galli V.; Pracucci C.; Occupati B.; Mannaioni G. | |
| Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study | 2021 | Cosci F.; Svicher A.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Guidi J.; Zipfel S. | |
| Mental pain as a global person-centred outcome measure | 2021 | Cosci F.; Mansueto G.; Benemei S.; Chiarugi A.; De Cesaris F.; Sensky T. | |
| Mental Pain Questionnaire: An item response theory analysis | 2019 | Svicher, A.; Romanazzo, S.; De Cesaris, F.; Benemei, S.; Geppetti, P.; Cosci, F. | |
| Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure | 2024 | Cosci Fiammetta; Carrozzino Danilo; Patierno Chiara; Romanazzo Sara; Berrocal Carmen; Chiarugi Alberto; De Cesaris Francesco; Guiducci Serena; Mansueto Giovanni; Christensen KajSparle; Sensky Tom | |
| Migraine during covid-19: Data from second wave pandemic in an Italian cohort | 2021 | Gentile E.; Delussi M.; Abagnale C.; Caponnetto V.; De Cesaris F.; Frattale I.; Guaschino E.; Marcinno A.; Ornello R.; Pistoia F.; Putorti A.; Candida G.; Roveta F.; Lupi C.; Coppola G.; Prudenzano A.M.P.; Rainero I.; Sances G.; Roca M.E.; Trojano M.; Pierelli F.; Geppetti P.; Sacco S.; de Tommaso M. | |
| Migraine Models | 2009 | S. Benemei; F. De Cesaris; P. Nicoletti; S. Materazzi; R. Nassini; P. Geppetti. | |
| Migraine-provoking substances evoke periorbital allodynia in mice | 2019 | De Logu F.; Landini L.; Janal M.N.; Li Puma S.; De Cesaris F.; Geppetti P.; Nassini R. | |
| Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study | 2024 | Burgalassi, Andrea; Romozzi, Marina; Vigani, Giulia; De Icco, Roberto; Raffaelli, Bianca; Boccalini, Alberto; De Cesaris, Francesco; Calabresi, Paolo; Geppetti, Pierangelo; Chiarugi, Alberto; Iannone, Luigi Francesco | |
| Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses | 2017 | Felici, Roberta; Buonvicino, Daniela; Muzzi, Mirko; Cavone, Leonardo; Guasti, Daniele; Lapucci, Andrea; Pratesi, Sara; De Cesaris, Francesco; Luceri, Francesca; Chiarugi, Alberto |